RLYB
Rallybio Corp
17.10$
+2.6%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +34.9% | |
| – | +135.5% | +75.7% | +53.2% | -10.2% | +26,238.0% | -99.8% | |
| – | – | – | – | – | – | – | |
| – | +55.1% | +52.6% | +51.2% | +31.6% | -22.5% | -52.8% | |
| – | +22.3% | +144.2% | +45.1% | -6.6% | -27.8% | -21.8% | |
| – | +43.4% | +80.4% | +48.7% | +16.3% | -72.6% | +33.3% | |
| – | – | – | – | – | – | – | |
| – | +25.6% | -79.6% | +22,950.0% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | -109.0% | – | -171.6% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.